Abstract
Purpose
Women with personal history of breast cancer (PHBC) are currently recommended to receive annual mammography for surveillance of breast cancer recurrence or new primary. However, given issues in accuracy with mammography, there is a need for evolving evidence-based surveillance recommendations with supplemental imaging. In this systematic review, we compiled and compared existing studies that describe the test performance of surveillance breast MRI among women with PHBC.
Methods
We searched PubMed and EMBASE using MeSH terms for studies (2000–2019) that described the diagnostic characteristics of breast MRI in women with PHBC. Search results were reviewed and included based on PICOTS criteria; quality of included articles was assessed using QUADAS-2. Meta-analysis of single proportions was conducted for diagnostic characteristics of breast MRI, including tests of heterogeneity.
Results
Our review included 11 articles in which unique cohorts were studied, comprised of a total of 8338 women with PHBC and 12,335 breast MRI done for the purpose of surveillance. We predict intervals (PI) for cancer detection rate per 1000 examinations (PI 9–15; I2 = 10%), recall rate (PI 5–31%; I2 = 97%), sensitivity (PI 58–95%; I2 = 47%), specificity (PI 76–97%; I2 = 97%), and PPV3 (PI 16–40%; I2 = 44%).
Conclusions
Studies addressing performance of breast MRI are variable and limited in population-based studies. The summary of evidence to date is insufficient to recommend for or against use of breast MRI for surveillance among women with PHBC.
Similar content being viewed by others
Abbreviations
- PHBC:
-
Personal history of breast cancer
- BCSC:
-
Breast Cancer Surveillance Consortium
- MRI:
-
Magnetic resonance imaging
References
American Cancer Society (2016) Cancer treatment & survivorship: facts & figures 2016–2017. American Cancer Society, Atlanta, p 44
Howlader N et al (2016) SEER cancer statistics review, 1975–2013. National Cancer Institute, Bethesda
Howlader N et al (2012) SEER cancer statistics review, 1975–2009 (Vintage 2009 Publications). 2012. http://seer.cancer.gov/csr/1975_2009_pops09/index.html. Accessed 16 Jan 2013
Lash TL et al (2007) Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 25(21):3001–3006
Houssami N et al (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20(9):1505–1510
Lu WL et al (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114(3):403–412
Lu W et al (2009) The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer. Eur J Cancer 45(17):3000–3007
Sardanelli F et al (2016) Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur Radiol
Houssami N et al (2011) Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 305(8):790–799
Wernli KJ et al (2019) Surveillance breast MRI and mammography: comparison in women with a personal history of breast cancer. Radiology 292(2):311–318
Quinn EM, Coveney AP, Redmond HP (2012) Use of magnetic resonance imaging in detection of breast cancer recurrence: a systematic review. Ann Surg Oncol 19(9):3035–3041
American College of Radiology (2013) American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS® Atlas). American College of Radiology (ACR), Reston
American Cancer Society (2015) American Cancer Society recommendations for early breast cancer detection in women without breast symptoms. 2015 October 20. http://www.cancer.org/cancer/breastcancer/moreinformation/breastcancerearlydetection/breast-cancer-early-detection-acs-recs. Accessed 1 December 2015
Liu Z et al (2013) A step-by-step guide to the systematic review and meta-analysis of diagnostic and prognostic test accuracy evaluations. Br J Cancer 108(11):2299–2303
Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097
Innovation VH. Covidence systematic review software
Whiting PF et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536
Higgins JP, Thompson SG, Spiegelhalter DJ (2009) A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 172(1):137–159
Berg WA et al (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299(18):2151–2163
Brennan S et al (2010) Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol 195(2):510–516
Schacht DV et al (2014) Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR Am J Roentgenol 202(2):289–292
Cho N et al (2017) Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy. JAMA Oncol 3(11):1495–1502
Elmore L, Margenthaler JA (2010) Breast MRI surveillance in women with prior curative-intent therapy for breast cancer. J Surg Res 163(1):58–62
Giess CS et al (2015) Screening breast MRI in patients previously treated for breast cancer: diagnostic yield for cancer and abnormal interpretation rate. Acad Radiol 22(11):1331–1337
Gweon HM et al (2014) Breast MR imaging screening in women with a history of breast conservation therapy. Radiology 272(2):366–373
Lehman CD et al (2016) Screening MRI in women with a personal history of breast cancer. J Natl Cancer Inst 108(3):349
Sippo DA et al (2019) Performance of screening breast MRI across women with different elevated breast cancer risk indications. Radiology 292(1):51–59
Weinstock C et al (2015) Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors. Springerplus 4:459
Berg WA et al (2012) Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307(13):1394–1404
Leeflang MM (2014) Systematic reviews and meta-analyses of diagnostic test accuracy. Clin Microbiol Infect 20(2):105–113
Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20(19):2865–2884
Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012
Zwinderman AH, Bossuyt PM (2008) We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med 27(5):687–697
Lee CH et al (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1):18–27
Ahern CH et al (2014) Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. Br J Cancer 111(8):1542–1551
Kramer S et al (1998) Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer. Anticancer Res 18(3C):2159–2161
Preda L et al (2006) Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res 8(5):R53
Coulthard A, Beveridge CJ, Potterton AJ (1999) MRI in routine breast cancer follow-up: correlation with clinical outcome. Clin Radiol 54(7):459–461
Arazi-Kleinman T et al (2013) JOURNAL CLUB: is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results. AJR Am J Roentgenol 201(4):919–927
Rieber A et al (1997) Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr 21(5):780–784
Viehweg P et al (1998) Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy. MAGMA 7(3):141–152
Cuzick J et al (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135–1141
Dubsky PC et al (2012) Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 30(7):722–728
Early Breast Cancer Trialists’ Collaborative G et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716
Poggi MM et al (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98(4):697–702
Punglia RS, Hassett MJ (2010) Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors. J Clin Oncol 28(27):4108–4110
Veronesi U et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232
Bassett LW et al (2008) National trends and practices in breast MRI. AJR Am J Roentgenol 191(2):332–339
Stout NK, Nekhlyudov L (2011) Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004. J Womens Health (Larchmt) 20(4):631–634
Wernli KJ et al (2014) Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med 174(1):125–132
Khatcheressian JL et al (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091–5097
Saslow D et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89
Mainiero MB et al (2013) ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 10(1):11–14
Khatcheressian JL et al (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(7):961–965
Morrow M, Waters J, Morris E (2011) MRI for breast cancer screening, diagnosis, and treatment. Lancet 378(9805):1804–1811
Sickles EA (2010) The use of breast imaging to screen women at high risk for cancer. Radiol Clin North Am 48(5):859–878
Monticciolo DL et al (2018) Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol 15(3):408–414
Buist DSM et al (2018) Breast biopsy intensity and findings following breast cancer screening in women with and without a personal history of breast cancer. JAMA Intern Med 178(4):458–468
Funding
This work was supported through a Patient-Centered Outcomes Research Institute (PCORI) Project Program Award (CE-1304-6656-Comparative effectiveness of surveillance imaging modalities in breast cancer survivors). The design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication is solely the responsibility of the authors and does not necessarily represent the official views of the Patient-Centered Outcomes Research Institute. This publication was supported by grant number T32 CA094880 from the National Institute of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCI, NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors CBH, LN, JML, SHJ, MB, DJ, CK, JS, SS, and KJW declare that they have no conflicts of interest. Dr Gleason owns stock in Radia Inc.
Research involving human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Haas, C.B., Nekhlyudov, L., Lee, J.M. et al. Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis. Breast Cancer Res Treat 181, 255–268 (2020). https://doi.org/10.1007/s10549-020-05637-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-020-05637-y